HealthTree Research for Myeloma - HealthTree for Multiple Myeloma

HealthTree Research

HealthTree Cure Hub is an online patient portal that invites patients to contribute to research.

There are over 11,000 registered patients in HealthTree Cure Hub and many have willingly helped contribute their myeloma story (anonymously) to speed academic research.

The HealthTree Research articles are findings from these online surveys, from data inside the database, and from larger studies. Some of the surveys and studies have been performed to support specific myeloma investigator's work. Others have been performed internally at HealthTree.

Myeloma investigators have called HealthTree Cure Hub a "hypotheses generation tool."

We are intensely grateful for patients who have contributed to this significant and important research and look forward to publishing many more results.

Accelerating Immunotherapy Research in Multiple Myeloma

October 02, 2023

Dr. Omar Nadeem presented about immunotherapy for multiple myeloma patients at the Boston Myeloma Round Table and shared how research continues to accelerate.

Potential Outpatient CAR-T Treatment for Multiple Myeloma

October 02, 2023

Learn about the product NXC-201, a CAR-T that overcomes neurotoxicities, treats amyloidosis, and is potentially the first to be outpatient.

Understanding Patient Perspectives Toward Participation in Multiple Myeloma Clinical Trials

June 01, 2023

HealthTree Researchers discover myeloma patients' perspective on participating in clinical trials.

Top Myeloma Patient Concerns and the HealthTree Coach Program

April 10, 2023

HealthTree performed a study to learn about the top concerns of newly diagnosed myeloma patients.

What Multiple Myeloma Patients Think About MRD Testing

March 16, 2023

HealthTree Foundation and Adaptive joined forces to understand the awareness, knowledge, and perceptions of MRD testing among patients with multiple myeloma.